News | December 26, 2025
Biofabri and Bharat Biotech ink tech transfer pact to boost global TB vaccine access
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra, a second brand of Novo Nordisk’s Semaglutide injection for weight management
The study is being conducted under a USFDA IND, has received U.S. Fast Track Designation for SLE-ITP, and has obtained IND approval from China’s Center for Drug Evaluation
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
Clinical trial enrollment has long been a bottleneck in drug development
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
It's an acquisition that aims at forming one of the US's largest oncology trial networks
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
AEF0217 is a first-in-class CB1 receptor signaling-specific inhibitor
The company also revealed that MK-2214 has received Fast Track Designation from the U.S. Food and Drug Administration
Subscribe To Our Newsletter & Stay Updated
